Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
0.4875
+0.0083 (1.73%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Verrica Pharmaceuticals Employees
Verrica Pharmaceuticals had 71 employees as of December 31, 2024. The number of employees decreased by 29 or -29.00% compared to the previous year.
Employees
71
Change (1Y)
-29
Growth (1Y)
-29.00%
Revenue / Employee
$106,563
Profits / Employee
-$1,078,577
Market Cap
45.02M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
VRCA News
- 16 days ago - Verrica Pharmaceuticals Appoints Gavin Corcoran, M.D. to its Board of Directors - GlobeNewsWire
- 19 days ago - Verrica Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 24 days ago - Verrica Pharmaceuticals Appoints Noah L. Rosenberg, M.D. - GlobeNewsWire
- 5 weeks ago - Verrica Pharmaceuticals, Inc. (VRCA) Q4 2024 Earnings Conference Call Transcript - Seeking Alpha
- 5 weeks ago - Verrica Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 6 weeks ago - Verrica Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results and Provide a Corporate Update on March 11, 2025 - GlobeNewsWire
- 7 weeks ago - Verrica Pharmaceuticals to Participate in the TD Cowen 45th Annual Health Care Conference in Boston - GlobeNewsWire
- 4 months ago - Verrica Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire